Stock Analysis

Endo Manufacturing First Quarter 2025 Earnings: EPS: JP¥15.39 (vs JP¥40.44 in 1Q 2024)

TSE:7841
Source: Shutterstock

Endo Manufacturing (TSE:7841) First Quarter 2025 Results

Key Financial Results

  • Revenue: JP¥4.59b (up 6.1% from 1Q 2024).
  • Net income: JP¥135.0m (down 62% from 1Q 2024).
  • Profit margin: 2.9% (down from 8.2% in 1Q 2024). The decrease in margin was driven by higher expenses.
  • EPS: JP¥15.39 (down from JP¥40.44 in 1Q 2024).
We've discovered 3 warning signs about Endo Manufacturing. View them for free.
earnings-and-revenue-history
TSE:7841 Earnings and Revenue History May 9th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Endo Manufacturing shares are down 3.5% from a week ago.

Risk Analysis

We don't want to rain on the parade too much, but we did also find 3 warning signs for Endo Manufacturing that you need to be mindful of.

If you're looking to trade Endo Manufacturing, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.

With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.

Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.

Sponsored Content

Valuation is complex, but we're here to simplify it.

Discover if Endo Manufacturing might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.